When Can You Ban Parallel Trade?
This article was originally published in Scrip
Taking steps to prevent medicines being parallel exported from on EU country to another is always fraught with uncertainty, despite a succession of rulings on the matter by the Court of Justice of the EU. And a recent statement by Health Commissioner Vytenis Andriukaitis, appearing to conflict with action being taken by the commission's internal market directorate, has done little to clarify the situation.
You may also be interested in...
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.